XBiotech Inc. (XBIT): Total Liabilities
$9.73M
As of 2025-12-31
$5.19M
As of 2026-06-30
+19.5%
3-year compound annual growth
+13.8%
5-year compound annual growth
+4.4%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.73M | -42.2% | 2026-03-13, Balance as of period end |
| 2024-12-31 | $16.82M | +116.6% | 2026-03-13, Balance as of period end |
| 2023-12-31 | $7.77M | +36.3% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $5.70M | -1.6% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $5.79M | +13.5% | 2023-03-15, Balance as of period end |
| 2020-12-31 | $5.11M | -91.7% | 2022-03-15, Balance as of period end |
| 2019-12-31 | $61.25M | n/m | 2021-03-16, Balance as of period end |
| 2018-12-31 | $2.95M | +4.9% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $2.81M | -64.8% | 2019-03-15, Balance as of period end |
| 2016-12-31 | $7.99M | +26.6% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $6.31M | +100.4% | 2017-03-16, Balance as of period end |
| 2014-12-31 | $3.15M | n/a | 2016-04-15, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| XBiotech Inc. (XBIT) | 2025-12-31 | $9.73M | -42.2% |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | $14.52M | -18.6% |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | $20.27M | -15.3% |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | $52.56M | -56.6% |
| Veradermics, Inc (MANE) | 2025-12-31 | $9.16M | +94.1% |
| Larimar Therapeutics, Inc. (LRMR) | 2025-12-31 | $67.76M | +138.5% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $119.41M | +123.3% |
| Precigen, Inc. (PGEN) | 2025-12-31 | $134.59M | +71.4% |
| Boundless Bio, Inc. (BOLD) | 2025-12-31 | $58.41M | +4.7% |
Compare XBIT, WHWK, OVID, CTMX side by side · Screen every company in Pharmaceutical Preparations ↗